Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10412 (
H1.4
)
75
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Histone H1 has seven variants in human somatic cells and contributes to chromatin compaction and transcriptional regulation. Knock-down (KD) of each H1 variant in breast cancer cells results in altered gene expression and proliferation differently in a variant specific manner with H1.2 and
H1.4
KDs being most deleterious. Here we show combined depletion of H1.2 and
H1.4
has a strong deleterious effect resulting in a strong
interferon
(
IFN
) response, as evidenced by an up-regulation of many
IFN
-stimulated genes (ISGs) not seen in individual nor in other combinations of H1 variant KDs. Although H1 participates to repress ISG promoters,
IFN
activation upon H1.2 and
H1.4
KD is mainly generated through the activation of the
IFN
response by cytosolic nucleic acid receptors and
IFN
synthesis, and without changes in histone modifications at induced ISG promoters. H1.2 and
H1.4
co-KD also promotes the appearance of accessibility sites genome wide and, particularly, at satellites and other repeats. The
IFN
response may be triggered by the expression of noncoding RNA generated from heterochromatic repeats or endogenous retroviruses upon H1 KD. In conclusion, redundant H1-mediated silencing of heterochromatin is important to maintain cell homeostasis and to avoid an unspecific
IFN
response.
...
PMID:Histone H1 depletion triggers an interferon response in cancer cells via activation of heterochromatic repeats. 2897 26